High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease: whole exome sequencing 90% at 20X in blood/buccal for NCI (DE vivo)

Ended Awarded Last action

Contract number
75N92021F00003
Awardee
Awarding agency
Obligated
$900,600

Award facts

Contract value 100% obligated
$900,600.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21218, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $900,600

About this award

This is a $900,600 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Johns Hopkins University. The contract is for whole exome sequencing services to study the genetic contributions to human health and disease. The work will be performed in Baltimore, Maryland and the period of performance runs through December 31, 2025. This delivery order contract is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract vehicle that allows the NCI to obtain high-throughput genotyping and DNA sequencing services. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N92021F00003?

75N92021F00003 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on August 4, 2021.

How much is contract 75N92021F00003 worth?

The government has obligated $900,600 on 75N92021F00003.

Which agency awarded contract 75N92021F00003?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021F00003, with funding from National Cancer Institute (National Institutes of Health).

Is contract 75N92021F00003 an order under another contract?

Yes. 75N92021F00003 is a delivery order under HHSN268201700006I, an indefinite delivery contract.

Was contract 75N92021F00003 competed?

The extent of competition for 75N92021F00003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award